Quick Takeaways
- Commodore Capital LP filed SCHEDULE 13G for LB PHARMACEUTICALS INC Common Stock, $0.0001 par value per share.
- Disclosed ownership: 5.5%.
- Date of event: 11 Sep 2025.
Commodore Capital LP - 11 Sep 2025 SCHEDULE 13G Report for LB PHARMACEUTICALS INC Common Stock, $0.0001 par value per share
- Filing Manager
- Commodore Capital LP
- Reporting Manager
- Commodore Capital LP
- Shares outstanding
- 22,272,727 shares
- Disclosed Ownership
- 1,225,000 shares
- Ownership
- 5.5%
- Form type
- SCHEDULE 13G
- Filing time
- 18 Sep 2025, 16:01:49 UTC
- Date of event
- 11 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Commodore Capital LP disclosed 5.5% ownership in LB PHARMACEUTICALS INC Common Stock, $0.0001 par value per share on 11 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 18 Sep 2025, 16:01.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Commodore Capital LP | 5.5% | 1,225,000 | 0 | 1,225,000 | Michael Kramarz | Managing Partner | |
| Commodore Capital Master LP | 5.5% | 1,225,000 | 0 | 1,225,000 | Michael Kramarz | Authorized Signatory | |
| Robert Egen Atkinson | 5.5% | 1,225,000 | 0 | 1,225,000 | Robert Egen Atkinson | Authorized Sigantory | |
| Michael Kramarz | 5.5% | 1,225,000 | 0 | 1,225,000 | Michael Kramarz | Authorized Signatory |